Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse.
Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key ...
The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.
Experts offer treatment tips for patients with axial spondyloarthritis who also have inflammatory bowel disease.
Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key ...
Dr Jayant Arora explains the key differences between rheumatoid arthritis and osteoarthritis. Here is what you should know ...
Inflammatory bowel diseases (IBDs) such as ulcerative colitis and Crohn's disease affect around 3,000 people in Singapore and ...
If mornings now begin with stiff knees, achy hips or hands that need a minute to get going, you're far from alone. More than ...
Red and blue light therapy devices have officially become the newest beauty shelfies, with creators flooding TikTok and ...
Most people with Crohn’s disease or ulcerative colitis report experiencing some form of stigma, or unfair treatment due to ...
The FDA has granted Coya 302 a fast-track designation for ALS, according to a press release from Coya Therapeutics. “ALS is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results